Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Guidelines for the Content of Statistical Analysis Plans in Clinical TrialsJAMA : the journal of the American Medical Association, 2017-12, Vol.318 (23), p.2337 [Peer Reviewed Journal]EISSN: 1538-3598 ;DOI: 10.1001/jama.2017.18556 ;PMID: 29260229Digital Resources/Online E-Resources |
|
2 |
Material Type: Article
|
Combining epigenetic drugs with other therapies for solid tumours - past lessons and future promiseNature reviews. Clinical oncology, 2020-02, Vol.17 (2), p.91-107 [Peer Reviewed Journal]COPYRIGHT 2020 Nature Publishing Group ;2019© Springer Nature Limited 2019 ;Springer Nature Limited 2019. ;Copyright ;ISSN: 1759-4774 ;EISSN: 1759-4782 ;DOI: 10.1038/s41571-019-0267-4 ;PMID: 31570827Full text available |
|
3 |
Material Type: Article
|
Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLMClinical chemistry (Baltimore, Md.), 2018-07, Vol.64 (7), p.1006-1033 [Peer Reviewed Journal]2018 American Association for Clinical Chemistry. ;COPYRIGHT 2018 American Association for Clinical Chemistry, Inc. ;Copyright American Association for Clinical Chemistry Jul 2018 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0009-9147 ;EISSN: 1530-8561 ;DOI: 10.1373/clinchem.2018.287037 ;PMID: 29760220Full text available |
|
4 |
Material Type: Article
|
Alzheimer's disease drug development pipeline: 2022Alzheimer's & dementia : translational research & clinical interventions, 2022, Vol.8 (1), p.e12295-n/a [Peer Reviewed Journal]2022 The Authors. published by Wiley Periodicals, LLC on behalf of Alzheimer's Association ;2022 The Authors. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring published by Wiley Periodicals, LLC on behalf of Alzheimer's Association. ;2022. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2352-8737 ;EISSN: 2352-8737 ;DOI: 10.1002/trc2.12295 ;PMID: 35516416Full text available |
|
5 |
Material Type: Article
|
Increasing Black, Indigenous and People of Color participation in clinical trials through community engagement and recruitment goal establishmentPloS one, 2021-10, Vol.16 (10), p.e0258858-e0258858 [Peer Reviewed Journal]COPYRIGHT 2021 Public Library of Science ;This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication: https://creativecommons.org/publicdomain/zero/1.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0258858 ;PMID: 34665829Full text available |
|
6 |
Material Type: Article
|
Timing and completeness of trial results posted at ClinicalTrials.gov and published in journalsPLoS medicine, 2013-12, Vol.10 (12), p.e1001566; discussion e1001566-e1001566; discussion e1001566 [Peer Reviewed Journal]COPYRIGHT 2013 Public Library of Science ;COPYRIGHT 2013 Public Library of Science ;2013 Riveros et al 2013 Riveros et al ;2013 Riveros et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Riveros C, Dechartres A, Perrodeau E, Haneef R, Boutron I, et al. (2013) Timing and Completeness of Trial Results Posted at ClinicalTrials.gov and Published in Journals. PLoS Med 10(12): e1001566. doi:10.1371/journal.pmed.1001566 ;ISSN: 1549-1676 ;ISSN: 1549-1277 ;EISSN: 1549-1676 ;DOI: 10.1371/journal.pmed.1001566 ;PMID: 24311990Full text available |
|
7 |
Material Type: Article
|
Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort studyIntensive care medicine, 2023-02, Vol.49 (2), p.178-190 [Peer Reviewed Journal]Springer-Verlag GmbH Germany, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. ;2023. Springer-Verlag GmbH Germany, part of Springer Nature. ;COPYRIGHT 2023 Springer ;Distributed under a Creative Commons Attribution 4.0 International License ;Springer-Verlag GmbH Germany, part of Springer Nature 2023, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. ;ISSN: 0342-4642 ;ISSN: 1432-1238 ;EISSN: 1432-1238 ;DOI: 10.1007/s00134-022-06944-2 ;PMID: 36764959Full text available |
|
8 |
Material Type: Article
|
Efficacy and safety of patisiran for familial amyloidotic polyneuropathy: a phase II multi-dose studyOrphanet journal of rare diseases, 2015-09, Vol.10 (1), p.109-109, Article 109 [Peer Reviewed Journal]COPYRIGHT 2015 BioMed Central Ltd. ;COPYRIGHT 2015 BioMed Central Ltd. ;Copyright BioMed Central 2015 ;Distributed under a Creative Commons Attribution 4.0 International License ;Suhr et al. 2015 ;ISSN: 1750-1172 ;EISSN: 1750-1172 ;DOI: 10.1186/s13023-015-0326-6 ;PMID: 26338094Full text available |
|
9 |
Material Type: Article
|
Systematic review finds that study data not published in full text articles have unclear impact on meta-analyses results in medical researchPloS one, 2017-04, Vol.12 (4), p.e0176210-e0176210 [Peer Reviewed Journal]COPYRIGHT 2017 Public Library of Science ;COPYRIGHT 2017 Public Library of Science ;2017 Schmucker et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2017 Schmucker et al 2017 Schmucker et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0176210 ;PMID: 28441452Full text available |
|
10 |
Material Type: Article
|
Safety of SARS-CoV-2 vaccines: a systematic review and meta-analysis of randomized controlled trialsInfectious diseases of poverty, 2021-07, Vol.10 (1), p.94-94, Article 94 [Peer Reviewed Journal]COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 2049-9957 ;ISSN: 2095-5162 ;EISSN: 2049-9957 ;DOI: 10.1186/s40249-021-00878-5 ;PMID: 34225791Full text available |
|
11 |
Material Type: Article
|
Alzheimer's disease drug development pipeline: 2023Alzheimer's & dementia : translational research & clinical interventions, 2023-04, Vol.9 (2), p.e12385-n/a [Peer Reviewed Journal]2023 The Authors. published by Wiley Periodicals LLC on behalf of Alzheimer's Association. ;2023 The Authors. Alzheimer's & Dementia: Translational Research & Clinical Interventions published by Wiley Periodicals LLC on behalf of Alzheimer's Association. ;2023. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2352-8737 ;EISSN: 2352-8737 ;DOI: 10.1002/trc2.12385 ;PMID: 37251912Full text available |
|
12 |
Material Type: Article
|
Subcutaneous Methylnaltrexone as Treatment for Opioid-lnduced Constipation in Patients with Advanced Cancer and Noncancer Illnesses: A Post Hoc Analysis of Two Clinical TrialsJournal of pain research, 2023-02, Vol.16, p.395 [Peer Reviewed Journal]COPYRIGHT 2023 Dove Medical Press Limited ;ISSN: 1178-7090 ;EISSN: 1178-7090 ;DOI: 10.2147/JPR.S36646Full text available |
|
13 |
Material Type: Article
|
Dapagliflozin Added to Verinurad Plus Febuxostat Further Reduces Serum Uric Acid in Hyperuricemia: The QUARTZ StudyThe journal of clinical endocrinology and metabolism, 2021-05, Vol.106 (5), p.e2347-e2356 [Peer Reviewed Journal]The Author(s) 2020. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2020 ;Copyright © Oxford University Press 2015 ;The Author(s) 2020. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. ;COPYRIGHT 2021 Oxford University Press ;The Author(s) 2020. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com ;ISSN: 0021-972X ;EISSN: 1945-7197 ;DOI: 10.1210/clinem/dgaa748 ;PMID: 33075806Full text available |
|
14 |
Material Type: Article
|
The use of RNA-based treatments in the field of cancer immunotherapyMolecular cancer, 2023-07, Vol.22 (1), p.106-106, Article 106 [Peer Reviewed Journal]2023. The Author(s). ;COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;BioMed Central Ltd., part of Springer Nature 2023 ;ISSN: 1476-4598 ;EISSN: 1476-4598 ;DOI: 10.1186/s12943-023-01807-w ;PMID: 37420174Full text available |
|
15 |
Material Type: Article
|
The Use of Patient-Reported Outcome Measures in Phase I Oncology Clinical TrialsOncology, 2021-06, Vol.99 (7), p.444-453 [Peer Reviewed Journal]2021 The Author(s) Published by S. Karger AG, Basel ;2021 The Author(s) Published by S. Karger AG, Basel. ;COPYRIGHT 2021 S. Karger AG ;ISSN: 0030-2414 ;EISSN: 1423-0232 ;DOI: 10.1159/000514874 ;PMID: 33823518Digital Resources/Online E-Resources |
|
16 |
Material Type: Article
|
Phase I Study of Afatinib and Selumetinib in Patients with KRAS‐Mutated Colorectal, Non‐Small Cell Lung, and Pancreatic CancerThe oncologist (Dayton, Ohio), 2021-04, Vol.26 (4), p.290-e545 [Peer Reviewed Journal]AlphaMed Press; the data published online to support this summary are the property of the authors. ;COPYRIGHT 2021 Oxford University Press ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1002/onco.13631 ;PMID: 33296125Full text available |
|
17 |
Material Type: Article
|
Cardiovascular Adverse Events Reported from COVID-19 Vaccines: A Study Based on WHO DatabaseInternational journal of general medicine, 2021-07, Vol.14, p.3909-3927 [Peer Reviewed Journal]COPYRIGHT 2021 Dove Medical Press Limited ;2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Jeet Kaur et al. 2021 Jeet Kaur et al. ;ISSN: 1178-7074 ;EISSN: 1178-7074 ;DOI: 10.2147/IJGM.S324349 ;PMID: 34349544Full text available |
|
18 |
Material Type: Article
|
BATTLING 'SLUDGE' IN CLINICAL TRIALS: A CALL TO ACTIONApplied clinical trials, 2024-04, Vol.33 (4), p.10-11 [Peer Reviewed Journal]COPYRIGHT 2024 Intellisphere, LLC ;Copyright MultiMedia Healthcare Inc. Apr 2024 ;ISSN: 1064-8542 ;EISSN: 2150-623XDigital Resources/Online E-Resources |
|
19 |
Material Type: Article
|
Exploring PI3K[delta] Molecular Pathways in Stable COPD and Following an Acute Exacerbation, Two Randomized Controlled TrialsInternational journal of chronic obstructive pulmonary disease, 2021-06, Vol.16, p.1621 [Peer Reviewed Journal]COPYRIGHT 2021 Dove Medical Press Limited ;ISSN: 1178-2005 ;EISSN: 1178-2005 ;DOI: 10.2147/COPD.S309303Full text available |
|
20 |
Material Type: Article
|
Safety and immunogenicity of heterologous boost immunization with an adenovirus type-5-vectored and protein-subunit-based COVID-19 vaccinePLoS medicine, 2022-05, Vol.19 (5) [Peer Reviewed Journal]COPYRIGHT 2022 Public Library of Science ;ISSN: 1549-1277 ;EISSN: 1549-1676 ;DOI: 10.1371/journal.pmed.1003953Full text available |